Health Care·Biotechnology·$185.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.29 | N/A | +11.18% |
management commentary, guidance changes, and full analysis available with Pro.
| +11.18% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for the upcoming quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering value to our shareholders.
Amgen's earnings report showed a positive surprise in EPS, indicating stronger-than-expected profitability. However, the stock reacted negatively, declining by 1.77%. The lack of revenue data and forward guidance may have contributed to investor uncertainty.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Feb 2, 2026